Assessing the severity of hepatic encephalopathy

Indian Journal of Gastroenterology

Volumn 22, Issue SUPPL. 2, 2003, Pages

  Venkataraman, S ^a   Peter, S ^a   Chandy, George M ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Cirrhosis; Fulminant hepatic failure; Minimal hepatic encephalopathy; Portosystemic encephalopathy

Indexed keywords

AMINO ACID; AMMONIA; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; PROTEIN S 100; QUINOLINIC ACID;

AMMONIA BLOOD LEVEL; BLOOD CHEMISTRY; CONFERENCE PAPER; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; FLAPPING TREMOR; FULMINANT LIVER FAILURE; HEPATIC ENCEPHALOPATHY; HUMAN; INTRACRANIAL PRESSURE; LIVER CIRRHOSIS; LIVER FAILURE; MEASUREMENT; MINIMAL HEPATIC ENCEPHALOPATHY; PORTOSYSTEMIC ENCEPHALOPATHY INDEX; PSYCHOMETRY; QUANTITATIVE DIAGNOSIS;

AMMONIA; DIAGNOSTIC IMAGING; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, SOMATOSENSORY; HEPATIC ENCEPHALOPATHY; HUMANS; INTRACRANIAL PRESSURE; PSYCHOMETRICS; SEVERITY OF ILLNESS INDEX;

EID: 1442314276     PISSN: 02548860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Chen TS, Chen PS. Morgagni: his book, vision and views on hepatic coma. J Gastroenterol Hepatol 1996;11:1062-4.
2. Tandon BN. Hepatic encephalopathy syndromes. Indian J Gastroenterol 2003;22(Suppl 2):S4-S6.
3. Ferenci P, Lockwood A, Mullen K, Taster R, Weissenborn K, Blei AT and the members of the Working Party. Hepatic encephalopathy - Definition, nomenclature, diagnosis and quantification. Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-21.
4. Conn HO. Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 1977;22:541-50.
5. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977;72:573-83.
6. Kharbanda PS, Saraswat VA, Dhiman RK. Minimal hepatic encephalopathy: Diagnosis by neuropsychological and neurophysiological methods. Indian J Gastroenterol 2003;22(Suppl 2):S37-S41.
7. Karnaze DS, Bickford RG. Triphasic waves: a reassessment of their significance. Electroencephalogr Clin Neurophysiol 1984;57:193-8.
8. Parsons-Smith BG, Summerskill WHJ, Dawson AM, Sherlock S. The electroencephalograph in liver disease. Lancet 1957;ii:867-71.
9. Van der Rijt CC, Schalm SW, De Groot GH, De Vlieger M. Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroencephalogr Clin Neurophysiol 1984;57:423-6.
10. Ciancio A, Marchet A, Saracco G, et al. Spectral electroencephalogram analysis in hepatic encephalopathy and liver transplantation. Liver Transpl 2002;8:630-5.
11. Butterworth RF, Giguere JF, Michaud J, Lavoie J, Layrargues GP. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987;6:1-12.
12. Stahl J. Studies of the blood ammonia in liver disease. Ann Intern Med 1963;58:1-24.
13. Conn HO. Quantifying the severity of hepatic encephalopathy. In: Conn HO, Bircher J, Eds. Hepatic Encephalopathy: Syndromes and Therapies. Bloomington, Illinois: Medi-Ed Press. 1994: p. 13-26.
14. Kramer L, Tribl B, Gendo A, Zauner C, Schneider B, Ferenci P. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology 2000;31:30-4.
15. Shimamoto C, Hirata I, Katsu K. Breath and blood ammonia in liver cirrhosis. Hepatogastroenterology 2000;47:443-5
16. Mullen KD. Organizing a clinical trial with a new drug for hepatic encephalopathy: an experience with the FDA. Advances in Hepatic Encephalopathy and Metabolism in Liver Disease, ISHE. 1999: p. 427-30.
17. Yang SS, Chu NS, Liaw YF. Somatosensory evoked potentials in hepatic encephalopathy. Gastroenterology 1985;89:625-30.
18. Sandford SL, Tarter RE, Sclabassi R, Van Thiel DH. Sensory information processing in patients with nonalcoholic cirrhosis. Short-latency visual, auditory, and somatosensory event-related potentials. J Neurol Sci 1987;80:269-76.
19. Grimm G, Ferenci P, Katzenschlager R, Madl C, Schnee B, Lagnner AN, et al. Improvement of hepatic encephalopathy treated with flumazenil. Lancet 1988;ii:1392-4.
20. Zeneroli ML, Pinelli G, Gollini G, Penne A, Messori E, Zani G, et al. Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalopathy. Gut 1984;25:291-9.
21. Gazzard BG, Portmann B, Murray-Lyon IM, Williams R. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med 1975;44:615-26.
22. Mukherjee KK, Chhabra R, Khosla VK. Raised intracranial pressure in hepatic encephalopathy. Indian J Gastroenterol 2003;22(Suppl 2):S62-S65.
23. Watanabe A. Cerebral changes in hepatic encephalopathy. J Gastroenterol Hepatol 1998;13:752-60.
24. Taylor-Robinson SD, Oatridge A, Hajnal JV, Burroughs AK, McIntyre N, deSouza NM. MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab Brain Dis 1995;10:175-88.
25. Haussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M, et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994;107:1475-80.
26. Lee JH, Seo DW, Lee YS, Kim ST, Mun CW, Lim TH, et al. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve. Am J Gastroenterol 1999;94:2206-13.
27. Steigmann F, Szanto PB, Poulos A, Lim PE, Dubin A. Significance of serum aminograms in diagnosis and prognosis of liver diseases. J Clin Gastroenterol 1984;6:453-60.
28. Basile AS, Saito K, al-Mardini H, Record CO, Hughes RD, Harrison P, et al. The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy. Gastroenterology 1995;108:818-23.
29. Basile AS, Harrison PM, Hughes RD, Satio K, Li Y, Heys MP, et al. Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy. Hepatology 1994;19:112-21.
30. Wiltfang J, Nolte W, Otto M, Wildberg J, Weissenborn K, Kornhuber J, et al. Elevated serum levels of astroglial S100 beta in patients with liver cirrhosis indicate early and subclinical portal-systemic encephalopathy. Metab Brain Dis 1999;14:239-51.
31. Vergara F, Plum F, Duffy TE. Alpha-ketoglutaramate: increased concentrations in the cerebrospinal fluid of patients in hepatic coma. Science 1974;183:81-3.